PI
BMRN icon

PEAK6 Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

PEAK6 Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$425K Sell
6,047
-5,800
-49% -$485K ﹤0.01% 2410
2024
Q2 		$975K Buy
+11,847
New +$986K ﹤0.01% 1845
2023
Q3 		– Sell
-3,470
Closed -$301K – 4072
2023
Q2 		$301K Sell
3,470
-7,984
-70% -$751K ﹤0.01% 2595
2023
Q1 		$1.11M Buy
+11,454
New +$1.19M 0.01% 1757
2022
Q3 		– Sell
-7,999
Closed -$712K – 5015
2022
Q2 		$676K Buy
+7,999
New +$637K ﹤0.01% 3491
2022
Q1 		– Sell
-211
Closed -$19K – 5224
2021
Q4 		$19K Sell
211
-67,834
-100% -$5.6M ﹤0.01% 4808
2021
Q3 		$5.26M Buy
68,045
+25,629
+60% +$2.02M 0.01% 1118
2021
Q2 		$3.54M Sell
42,416
-28,996
-41% -$2.3M 0.01% 1372
2021
Q1 		$5.39M Buy
71,412
+69,196
+3,123% +$5.65M 0.01% 994
2020
Q4 		$194K Sell
2,216
-5,998
-73% -$476K ﹤0.01% 3764
2020
Q3 		$625K Buy
+8,214
New +$831K ﹤0.01% 2657
2020
Q2 		– Sell
-1,261
Closed -$125K – 4375
2020
Q1 		$107K Sell
1,261
-4,307
-77% -$371K ﹤0.01% 3258
2019
Q4 		$471K Sell
5,568
-41,991
-88% -$3.17M ﹤0.01% 2013
2019
Q3 		$3.21M Buy
47,559
+33,750
+244% +$2.6M 0.02% 961
2019
Q2 		$1.18M Buy
+13,809
New +$1.18M 0.01% 1672
2019
Q1 		– Sell
-43,953
Closed -$4.07M – 3837
2018
Q4 		$3.74M Sell
43,953
-17,877
-29% -$1.7M 0.02% 820
2018
Q3 		$6M Buy
+61,830
New +$6.17M 0.03% 696

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

PEAK6 Investments's BMRN Position: Q3 2024 in Review

PEAK6 Investments reduced its BioMarin Pharmaceuticals (BMRN) stake by 49% in Q3 2024, selling an estimated $485K and leaving 6,047 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #2410.

PEAK6 Investments first reported a position in BMRN in Q3 2018 and has held it in 17 quarters since. The position peaked at $6M in Q3 2018. 553 funds tracked by Wall St. Rank hold BMRN as of Q3 2024.

  • PEAK6 Investments held 6,047 shares of BioMarin Pharmaceuticals worth $425K as of Q3 2024.
  • PEAK6 Investments sold 5,800 BioMarin Pharmaceuticals shares in Q3 2024, an estimated $485K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2410 holding.
  • PEAK6 Investments first reported a position in BioMarin Pharmaceuticals in Q3 2018 and has held it in 17 quarters since.
  • PEAK6 Investments's BioMarin Pharmaceuticals position peaked at $6M in Q3 2018.
  • 553 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.